Virtual National Blood Cancer Conference: Saturday, September 18, 2021

Click here to print the full agenda.

Start End Session Speaker
11:30 am, ET
10:30 am, CT
  9:30 am, MT
  8:30 am, PT
12:00 pm, ET
11:00 am, CT
10:00 am, MT
  9:00 am, PT
Exhibitor Session  
12:00 pm, ET
11:00 am, CT
10:00 am, MT
  9:00 am, PT
  1:00 pm, ET
12:00 pm, CT
11:00 am, MT
10:00 am, PT

Welcome

 

 


Keynote Presentation:
Blood Cancers and COVID-19

Louis DeGennaro, PhD
President & CEO
The Leukemia & Lymphoma Society
 

Thomas Kipps, MD, PhD
University of California, San Diego

  1:00 pm, ET
12:00 pm, CT
11:00 am, MT
10:00 am, PT
  1:15 pm, ET
12:15 pm, CT
11:15 am, MT
10:15 am, PT
Break/Exhibitor Session  
  1:15 pm, ET
12:15 pm, CT
11:15 am, MT
10:15 am, PT
  2:15 pm, ET
  1:15 pm, CT
12:15 pm, MT
11:15 am, PT
Concurrent Breakout Sessions  
    Myelodysplastic Syndromes (MDS) Lucy A. Godley, MD, PhD
The University of Chicago Medicine
    Adult Acute Myeloid Leukemia (AML) Eunice Wang, MD
Roswell Park Comprehensive Cancer Center
    Lymphoma High Grade

Jonathon B. Cohen, MD, MS

Winship Cancer Institute of Emory University

    Chronic Lymphocytic Leukemia (CLL) Anthony Mato, MD, MSCE
Memorial Sloan Kettering Cancer Center
    Waldenström Macroglobulinemia (WM) Steve P. Treon, MD, PhD
Dana-Farber Cancer Institute

Shayna Sarosiek, MD
Dana-Farber Cancer Institute
    Adult Acute Lymphoblastic Leukemia (ALL) Lori Muffly, MD
Stanford Cancer Institute
    Advances in CAR T-Cell Therapy Naveen Pemmaraju, MD
The University of Texas MD Anderson Cancer Center
    Supporting Your Health with Integrative Medicine Heather Greenlee, ND, PhD
Fred Hutchinson Cancer Research Center/Seattle Alliance Cancer Care
  2:15 pm, ET
  1:15 pm, CT
12:15 pm, MT
11:15 am, PT
  2:30 pm, ET
  1:30 pm, CT
12:30 pm, MT
11:30 am, PT
Break/Exhibitor Session  
  2:30 pm, ET
  1:30 pm, CT
12:30 pm, MT
11:30 am, PT
  3:30 pm, ET
  2:30 pm, CT
  1:30 pm, MT
12:30 pm, PT
Concurrent Breakout Sessions  
    Chronic Myeloid Leukemia (CML) Alison Wakoff Loren, MD, MSCE
Penn Medicine
    Lymphoma Low Grade

Alvaro Jose Alencar, MD
Sylvester Comprehensive Cancer Center

    Multiple Myeloma Brandon Blue, MD
Moffitt Cancer Center
    Myeloproliferative Neoplasms (MPN) Ruben Mesa, MD, FACP
Mays Cancer Center at UT Health San Antonio MD Anderson
    Hodgkin Lymphoma Kami J. Maddocks, MD
The James Cancer Hospital at The Ohio State University
    Advances in CAR T-Cell Therapy Naveen Pemmaraju, MD
The University of Texas MD Anderson Cancer Center
    Supporting Your Health with Integrative Medicine Heather Greenlee, ND, PhD
Fred Hutchinson Cancer Research Center/Seattle Alliance Cancer Care
  3:30 pm, ET
  2:30 pm, CT
  1:30 pm, MT
12:30 pm, PT
  Evaluations & Conference Concludes  

Follow LLS